Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Biopreservation Market Poised for Strong Growth Through 2033 as Cell and Gene Therapies, Biobanking, and Regenerative Medicine Drive Demand

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a leading company in the biopreservation market, which is poised for strong growth. This suggests a positive outlook for the company's involvement in this expanding sector. MRK Merck KGaA (MilliporeSigma) is identified as a leading company in the biopreservation market. The strong growth projected for this market indicates a positive outlook for Merck's contributions and performance within this sector. DHR Danaher Corporation, including its subsidiaries Cytiva & Pall Corporation, is recognized as a leading player in the biopreservation market. The strong growth forecast for this market suggests a positive outlook for Danaher's related business segments. BLFS BioLife Solutions, Inc. is identified as a leading company in the biopreservation market. The article's projection of strong growth for this market indicates a favorable environment for BioLife Solutions. CRSP Cryoport, Inc. is listed as a leading company in the biopreservation market. The strong growth forecast for this sector suggests a positive outlook for Cryoport's business operations and expansion. COHR Corning Incorporated is mentioned as a leading company in the biopreservation market. The article's projection of significant market growth implies a positive outlook for Corning's business in this sector. AVTR Avantor (VWR International) is listed as a leading company in the biopreservation market. The strong growth forecast for this market suggests a positive outlook for Avantor's business in this sector. GEHC GE Healthcare Life Sciences (Cytiva) is identified as a leading company in the biopreservation market. The strong growth projected for this market indicates a positive outlook for GE Healthcare's involvement and performance.

Biopreservation Market Poised for Strong Growth Through 2033 as Cell and Gene Therapies, Biobanking, and Regenerative Medicine Drive Demand Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Biopreservation Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.

Global Biopreservation Market to Reach USD 37.2 Billion by 2033, Driven by Regenerative Medicine and Biobanking Growth

The global biopreservation market is entering a period of significant expansion as healthcare organizations, biotechnology companies, research institutions, and biobanks increase their reliance on advanced storage technologies. Valued at USD 4.7 billion in 2026, the market is projected to reach USD 37.2 billion by 2033, representing a compound annual growth rate of 34.40% during the forecast period.

Growth is being supported by advances in regenerative medicine, stem cell therapies, personalized medicine, drug discovery, and biotechnology research. Cryopreservation, vitrification, and controlled-rate freezing technologies are improving the long-term viability and functionality of cells, tissues, organs, and other biological materials used in clinical and research applications.

Market Insights

Biopreservation has become an essential part of the global life sciences ecosystem. Increasing demand for reliable sample storage is encouraging investment in cryogenic equipment, preservation media, automated storage platforms, and Laboratory Information Management Systems (LIMS).

Automation is helping laboratories improve reproducibility, reduce operational risks, and minimize human error. At the same time, artificial intelligence and data analytics are being integrated into LIMS platforms to strengthen sample tracking, optimize storage capacity, manage inventory, and support regulatory compliance.

Key Biopreservation Market Drivers

Business Opportunities

The rapidly growing biopreservation market offers substantial opportunities for equipment manufacturers, technology developers, logistics providers, distributors, and specialized service companies. Demand is increasing for automated sample storage systems, advanced freezers, cryogenic equipment, specialized preservation media, temperature-controlled transportation, and AI-enabled LIMS solutions.

Emerging markets in Asia-Pacific and Latin America offer additional growth potential as governments and private organizations invest in healthcare infrastructure, biotechnology research, biobanking facilities, and clinical capabilities. Strategic partnerships, mergers, acquisitions, and research collaborations are expected to help market participants expand their technology portfolios and geographic reach.

Companies capable of delivering integrated biopreservation solutions may gain a competitive advantage. These solutions can combine sample preparation, preservation media, automated storage, real-time monitoring, inventory management, regulatory documentation, and temperature-controlled logistics.

Regional Market Outlook

North America currently leads the global biopreservation market due to its advanced healthcare infrastructure, substantial research and development spending, established biobanking networks, and strong presence of biotechnology and life sciences companies. The United States and Canada remain major contributors to regional demand.

Europe represents another important market, with Germany, the United Kingdom, and France investing in biobanking, cell therapy, and biopreservation technologies. Standardized regulatory and quality frameworks continue to support the development of reliable storage and handling practices.

Asia-Pacific is expected to emerge as a high-growth market, supported by expanding healthcare investment, rising biotechnology research, and increasing adoption of regenerative medicine. China, Japan, and India are accelerating the use of biopreservation products across clinical, academic, and commercial settings.

Latin America and the Middle East and Africa are also projected to record growth as healthcare expenditure rises and regional biobanking and biotechnology initiatives advance. Government programs and international research collaborations are expected to support further market development.

Leading Biopreservation Market Companies

Leading companies are prioritizing product development, strategic partnerships, acquisitions, and integrated service offerings to strengthen their positions in the global biopreservation industry.

Market Segmentation

By Product:

By Application:

By Region:

As demand for cell-based therapies, precision medicine, biotechnology research, and secure biological sample storage continues to increase, the global biopreservation market is positioned for sustained growth through 2033.

Key Topics Covered:

1. Executive Summary

1.1. Global Biopreservation Market Snapshot

1.2. Future Projections

1.3. Key Market Trends

1.4. Regional Snapshot, by Value, 2026

1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations

2.2. Market Dynamics

2.2.1. Drivers

2.2.2. Restraints

2.2.3. Market Opportunities

2.3. Value Chain Analysis

2.4. COVID-19 Impact Analysis

2.5. Porter's Five Forces Analysis

2.6. Impact of Russia-Ukraine Conflict

2.7. PESTLE Analysis

2.8. Regulatory Analysis

2.9. Price Trend Analysis

2.9.1. Current Prices and Future Projections, 2025-2033

2.9.2. Price Impact Factors

3. Global Biopreservation Market Outlook, 2020 - 2033

3.1. Global Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

3.1.1. Equipment

3.1.2. Media

3.1.3. Laboratory Information Management System (LIMS)

3.2. Global Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

3.2.1. Regenerative Medicine

3.2.2. Bio-banking

3.2.3. Drug Discovery

3.3. Global Biopreservation Market Outlook, by Region, Value (US$ Bn), 2020-2033

3.3.1. North America

3.3.2. Europe

3.3.3. Asia-Pacific

3.3.4. Latin America

3.3.5. Middle East & Africa

4. North America Biopreservation Market Outlook, 2020 - 2033

4.1. North America Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

4.1.1. Equipment

4.1.2. Media

4.1.3. Laboratory Information Management System (LIMS)

4.2. North America Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

4.2.1. Regenerative Medicine

4.2.2. Bio-banking

4.2.3. Drug Discovery

4.3. North America Biopreservation Market Outlook, by Country, Value (US$ Bn), 2020-2033

4.3.1. U.S. Biopreservation Market Outlook, by Product, 2020-2033

4.3.2. U.S. Biopreservation Market Outlook, by Application, 2020-2033

4.3.3. Canada Biopreservation Market Outlook, by Product, 2020-2033

4.3.4. Canada Biopreservation Market Outlook, by Application, 2020-2033

4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Biopreservation Market Outlook, 2020 - 2033

5.1. Europe Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

5.1.1. Equipment

5.1.2. Media

5.1.3. Laboratory Information Management System (LIMS)

5.2. Europe Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

5.2.1. Regenerative Medicine

5.2.2. Bio-banking

5.2.3. Drug Discovery

5.3. Europe Biopreservation Market Outlook, by Country, Value (US$ Bn), 2020-2033

5.3.1. Germany Biopreservation Market Outlook, by Product, 2020-2033

5.3.2. Germany Biopreservation Market Outlook, by Application, 2020-2033

5.3.3. Italy Biopreservation Market Outlook, by Product, 2020-2033

5.3.4. Italy Biopreservation Market Outlook, by Application, 2020-2033

5.3.5. France Biopreservation Market Outlook, by Product, 2020-2033

5.3.6. France Biopreservation Market Outlook, by Application, 2020-2033

5.3.7. U.K. Biopreservation Market Outlook, by Product, 2020-2033

5.3.8. U.K. Biopreservation Market Outlook, by Application, 2020-2033

5.3.9. Spain Biopreservation Market Outlook, by Product, 2020-2033

5.3.10. Spain Biopreservation Market Outlook, by Application, 2020-2033

5.3.11. Russia Biopreservation Market Outlook, by Product, 2020-2033

5.3.12. Russia Biopreservation Market Outlook, by Application, 2020-2033

5.3.13. Rest of Europe Biopreservation Market Outlook, by Product, 2020-2033

5.3.14. Rest of Europe Biopreservation Market Outlook, by Application, 2020-2033

5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia-Pacific Biopreservation Market Outlook, 2020 - 2033

6.1. Asia-Pacific Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

6.1.1. Equipment

6.1.2. Media

6.1.3. Laboratory Information Management System (LIMS)

6.2. Asia-Pacific Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

6.2.1. Regenerative Medicine

6.2.2. Bio-banking

6.2.3. Drug Discovery

6.3. Asia-Pacific Biopreservation Market Outlook, by Country, Value (US$ Bn), 2020-2033

6.3.1. China Biopreservation Market Outlook, by Product, 2020-2033

6.3.2. China Biopreservation Market Outlook, by Application, 2020-2033

6.3.3. Japan Biopreservation Market Outlook, by Product, 2020-2033

6.3.4. Japan Biopreservation Market Outlook, by Application, 2020-2033

6.3.5. South Korea Biopreservation Market Outlook, by Product, 2020-2033

6.3.6. South Korea Biopreservation Market Outlook, by Application, 2020-2033

6.3.7. India Biopreservation Market Outlook, by Product, 2020-2033

6.3.8. India Biopreservation Market Outlook, by Application, 2020-2033

6.3.9. Southeast Asia Biopreservation Market Outlook, by Product, 2020-2033

6.3.10. Southeast Asia Biopreservation Market Outlook, by Application, 2020-2033

6.3.11. Rest of SAO Biopreservation Market Outlook, by Product, 2020-2033

6.3.12. Rest of SAO Biopreservation Market Outlook, by Application, 2020-2033

6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Biopreservation Market Outlook, 2020 - 2033

7.1. Latin America Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

7.1.1. Equipment

7.1.2. Media

7.1.3. Laboratory Information Management System (LIMS)

7.2. Latin America Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

7.2.1. Regenerative Medicine

7.2.2. Bio-banking

7.2.3. Drug Discovery

7.3. Latin America Biopreservation Market Outlook, by Country, Value (US$ Bn), 2020-2033

7.3.1. Brazil Biopreservation Market Outlook, by Product, 2020-2033

7.3.2. Brazil Biopreservation Market Outlook, by Application, 2020-2033

7.3.3. Mexico Biopreservation Market Outlook, by Product, 2020-2033

7.3.4. Mexico Biopreservation Market Outlook, by Application, 2020-2033

7.3.5. Argentina Biopreservation Market Outlook, by Product, 2020-2033

7.3.6. Argentina Biopreservation Market Outlook, by Application, 2020-2033

7.3.7. Rest of LATAM Biopreservation Market Outlook, by Product, 2020-2033

7.3.8. Rest of LATAM Biopreservation Market Outlook, by Application, 2020-2033

7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Biopreservation Market Outlook, 2020 - 2033

8.1. Middle East & Africa Biopreservation Market Outlook, by Product, Value (US$ Bn), 2020-2033

8.1.1. Equipment

8.1.2. Media

8.1.3. Laboratory Information Management System (LIMS)

8.2. Middle East & Africa Biopreservation Market Outlook, by Application, Value (US$ Bn), 2020-2033

8.2.1. Regenerative Medicine

8.2.2. Bio-banking

8.2.3. Drug Discovery

8.3. Middle East & Africa Biopreservation Market Outlook, by Country, Value (US$ Bn), 2020-2033

8.3.1. GCC Biopreservation Market Outlook, by Product, 2020-2033

8.3.2. GCC Biopreservation Market Outlook, by Application, 2020-2033

8.3.3. South Africa Biopreservation Market Outlook, by Product, 2020-2033

8.3.4. South Africa Biopreservation Market Outlook, by Application, 2020-2033

8.3.5. Egypt Biopreservation Market Outlook, by Product, 2020-2033

8.3.6. Egypt Biopreservation Market Outlook, by Application, 2020-2033

8.3.7. Nigeria Biopreservation Market Outlook, by Product, 2020-2033

8.3.8. Nigeria Biopreservation Market Outlook, by Application, 2020-2033

8.3.9. Rest of Middle East Biopreservation Market Outlook, by Product, 2020-2033

8.3.10. Rest of Middle East Biopreservation Market Outlook, by Application, 2020-2033

8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap

9.2. Company Market Share Analysis, 2025

9.3. Competitive Dashboard

9.4. Company Profiles

9.4.1. Thermo Fisher Scientific

9.4.1.1. Company Overview

9.4.1.2. Product Portfolio

9.4.1.3. Financial Overview

9.4.1.4. Business Strategies and Developments

9.4.2. Merck KGaA (MilliporeSigma)

9.4.3. Sartorius AG

9.4.4. Danaher Corporation (including Cytiva & Pall Corporation)

9.4.5. BioLife Solutions, Inc.

9.4.6. Cryoport, Inc.

9.4.7. Corning Incorporated

9.4.8. VWR International (Avantor)

9.4.9. GE Healthcare Life Sciences (Cytiva)

9.4.10. STEMCELL Technologies Inc.

10. Appendix

10.1. Research Methodology

10.2. Report Assumptions

10.3. Acronyms and Abbreviations

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/ogoygi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.